Ascendis Pharma A (ASND) Debt Ratio (2021 - 2026)

Ascendis Pharma A has disclosed Debt Ratio across 6 years of filings, most recently posting 0.15 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.15, down 11.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.15 (down 11.84% YoY), and the FY2025 annual result was 0.49, up 200.32% from the prior year.
• Debt Ratio came in at 0.15 for Q1 2026 at Ascendis Pharma A, down from 0.49 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.5 in Q4 2022 to a low of 0.08 in Q2 2022.
• The 5-year median for Debt Ratio is 0.16 (2024), against an average of 0.21.
• Across the five-year window, Debt Ratio soared 852.93% in 2022 and sank 63.04% in 2024, its largest moves.
• Ascendis Pharma A's Debt Ratio stood at 0.5 in 2022, then retreated by 11.37% to 0.44 in 2023, then tumbled by 63.04% to 0.16 in 2024, then surged by 200.32% to 0.49 in 2025, then plunged by 70.56% to 0.15 in 2026.
• The last three Debt Ratio figures came in at 0.15 (Q1 2026), 0.49 (Q4 2025), and 0.2 (Q3 2025), per Business Quant data.